Is it time to reconsider neutrophil antibody testing of platelet donors?

Transfusion

Volumn 51, Issue 1, 2011, Pages 2-4

  Stroncek, David F ^a   Clay, Mary ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GRANULOCYTE ANTIBODY; HUMAN NEUTROPHIL ANTIGEN 1A; HUMAN NEUTROPHIL ANTIGEN 1B; HUMAN NEUTROPHIL ANTIGEN 2A; UNCLASSIFIED DRUG;

ANTIBODY SCREENING; BLOOD DONOR; BLOOD TRANSFUSION REACTION; EDITORIAL; GENE FREQUENCY; HLA SYSTEM; PHENOTYPE; THROMBOCYTE;

BLOOD DONORS; DONOR SELECTION; FEMALE; GENOTYPE; HUMANS; ISOANTIBODIES; ISOANTIGENS; MALE; NEUTROPHILS; PHENOTYPE; PLATELET TRANSFUSION; PREGNANCY;

EID: 78651373827     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02904.x     Document Type: Editorial

References (22)

1. Reil A, Wesche J, Greinacher A, Bux J,. Geno- and phenotyping and immunogenicity of HNA-3. Transfusion 2011; 51: 18-24.
2. Greinacher A, Wesche J, Hammer E, Furll B, Volker U, Reil A, Bux J,. Characterization of the human neutrophil alloantigen-3a. Nat Med 2010; 16: 45-8.
3. Curtis BR, Cox NJ, Sullivan MJ, Konkashbaev A, Bowens K, Hansen K, Aster RH,. The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 and appears to be encoded by an R>Q154 amino acid substitution. Blood 2010; 115: 2073-6.
4. Ory PA, Clark MR, Kwoh EE, Clarkson SB, Goldstein IM,. Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J Clin Invest 1989; 84: 1688-91.
5. Bux J, Stein EL, Bierling P, Fromont P, Clay M, Stroncek D, Santoso S,. Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood 1997; 89: 1027-34.
6. Kissel K, Santoso S, Hofmann C, Stroncek D, Bux J,. Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions. Eur J Immunol 2001; 31: 1301-9.
7. Kissel K, Scheffler S, Kerowgan M, Bux J,. Molecular basis of NB1 (HNA-2a, CD177) deficiency. Blood 2002; 99: 4231-3.
8. Simsek S, van der Schoot CE, Daams M, Huiskes E, Clay M, McCullough J, van Dalen C, Stroncek D, dem Borne AE. Molecular characterization of antigenic polymorphisms (Ond(a) and Mart(a)) of the beta 2 family recognized by human leukocyte alloantisera. Blood 1996; 88: 1350-8.
9. Kissel K, Hofmann C, Gittinger FS, Daniels G, Bux J,. HNA-1a, HNA-1b, and HNA-1c (NA1, NA2, SH) frequencies in African and American Blacks and in Chinese. Tissue Antigens 2000; 56: 143-8.
10. Sachs UJ, Reil A, Bauer C, Bux J, Bein G, Santoso S,. Genotyping of human neutrophil antigen-5a (Ond). Transfus Med 2005; 15: 115-7.
11. Clague HD, Fung YL, Minchinton RM,. Human neutrophil antigen-4a gene frequencies in an Australian population, determined by a new polymerase chain reaction method using sequence-specific primers. Transfus Med 2003; 13: 149-52.
12. Bux J, Chapman J,. Report on the second international granulocyte serology workshop. Transfusion 1997; 37: 977-83.
13. Bux J, Jung KD, Kauth T, Mueller-Eckhardt C,. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia. Transfus Med 1992; 2: 143-9.
14. Han TH, Chey MJ, Han KS,. Granulocyte antibodies in Korean neonates with neutropenia. J Korean Med Sci 2006; 21: 627-32.
15. Bux J, Behrens G, Jaeger G, Welte K,. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998; 91: 181-6.
16. Bruin M, Dassen A, Pajkrt D, Buddelmeyer L, Kuijpers T, de HM,. Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang 2005; 88: 52-9.
17. Taniuchi S, Masuda M, Hasui M, Tsuji S, Takahashi H, Kobayashi Y,. Differential diagnosis and clinical course of autoimmune neutropenia in infancy: comparison with congenital neutropenia. Acta Paediatr 2002; 91: 1179-82.
18. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA,. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002; 287: 1968-71.
19. Muniz M, Sheldon S, Schuller RM, Young NS, Klein HG, Leitman SF, Stroncek DF,. Patient-specific transfusion-related acute lung injury. Vox Sang 2008; 94: 70-3.
20. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH,. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003; 43: 641-5.
21. Reil A, Keller-Stanislawski B, Gunay S, Bux J,. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008; 95: 313-7.
22. Kleinman S, Grossman B, Kopko P,. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States. Transfusion 2010; 50: 1312-21.